Compare Deutsche Bank AG (DB) vs Moderna, Inc. (MRNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Moderna, Inc. — how do they compare? Deutsche Bank AG trades at $38.31 (market cap $71.96B), while Moderna, Inc. trades at $60.71 (market cap $24.18B). The key difference: Deutsche Bank AG is far larger — about 3× Moderna, Inc.'s market cap, and Deutsche Bank AG pays a 3.04% dividend while Moderna, Inc. pays none. Which is the better fit depends on your goals.
| DB | MRNA | |
|---|---|---|
Market Cap | $71.96B | $24.18B |
Sector | Financials | Health |
52-Week High | $40.33 | $81.80 |
52-Week Low | $28.37 | $22.36 |
Dividend Yield | 3.04% | — |
Enterprise Value | — | $20.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →
